International union of basic and clinical pharmacology. Cx. Classification of receptors for 5-hydroxytryptamine; pharmacology and function

  • Nicholas M. Barnes
  • , Gerard P. Ahern
  • , Carine Becamel
  • , Joël Bockaert
  • , Michael Camilleri
  • , Severine Chaumont-Dubel
  • , Sylvie Claeysen
  • , Kathryn A. Cunningham
  • , Kevin C. Fone
  • , Michael Gershon
  • , Giuseppe Di Giovanni
  • , Nathalie M. Goodfellow
  • , Adam L. Halberstadt
  • , Rachel M. Hartley
  • , Ghérici Hassaine
  • , Katharine Herrick-Davis
  • , Ruud Hovius
  • , Enza Lacivita
  • , Evelyn K. Lambe
  • , Marcello Leopoldo
  • Finn Olav Levy, Sarah C.R. Lummis, Philippe Marin, Luc Maroteaux, Andrew C. McCreary, David L. Nelson, John F. Neumaier, Adrian Newman-Tancredi, Hugues Nury, Alexander Roberts, Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. Villalón, Horst Vogel, Stephanie W. Watts, Daniel Hoyer

Research output: Contribution to journalArticlepeer-review

194 Scopus citations

Abstract

5-HT receptors expressed throughout the human body are targets for established therapeutics and various drugs in development. Their diversity of structure and function reflects the important role 5-HT receptors play in physiologic and pathophysiological processes. The present review offers a framework for the official receptor nomenclature and a detailed understanding of each of the 14 5-HT receptor subtypes, their roles in the systems of the body, and, where appropriate, the (potential) utility of therapeutics targeting these receptors.

Original languageEnglish (US)
Pages (from-to)310-520
Number of pages211
JournalPharmacological reviews
Volume73
Issue number1
DOIs
StatePublished - Jan 2021

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Fingerprint

Dive into the research topics of 'International union of basic and clinical pharmacology. Cx. Classification of receptors for 5-hydroxytryptamine; pharmacology and function'. Together they form a unique fingerprint.

Cite this